Shyam Century Ferrous Limited
SHYAMCENT · NSE · Basic Materials
StocksWizard rates Shyam Century Ferrous Limited a Sell, scoring 38/100 on our blended model. At ₹5.09 it trades below our blended DCF and relative-multiples fair value of ₹10.18, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 57/100 (grade C). It clears 3 of 8 investability checks, with durability 36, valuation 50 and momentum 24 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹8.14. Low-confidence estimate — limited data.
Investability checklist
- –ROE above 15%
- ✓Low debt (D/E < 0.5)0.01x
- ✕Positive free cash flow
- ✕Revenue growth > 10%-99%
- –Earnings growing
- ✕Net margin ≥ 10%-30.9%
- –Current ratio > 1.5
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- –Piotroski ≥ 7
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Well off its 52-week high — possible mean-reversion.
- •Trades ~100% below our estimated fair value.
About Shyam Century Ferrous Limited
Shyam Century Ferrous Limited engages in the manufacture and sale of ferro alloys in India. It provides ferro silicon products. The company is also involved in power generation activities
More in Basic Materials
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.